sitagliptin http://www.sitagliptin.org.uk... Sitagliptin, previously identified as MK-0431, is a new oral hypoglycemic
(anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. This
enzyme-inhibiting drug is to be used either alone or in combination with metformin or a
thiazolidinedione for control of type 2 diabetes mellitus.
Sitagliptina http://www.biotecnologica.com/sitagliptina-y-me... En el 43 Congreso Anual de la Asociacion Europea para el Estudio de la Diabetes (EADS), se da a conocer la combinacion de metformina y sitagliptina, con el nombre de Januvia que comercializa Merck Sharp y Dohme (MSD) demostrandose la mejora el control de la glucemia en pacientes con diabetes tipo 2.
